CLINICAL_TRIALS
trial_result
· 2021-04-14
Clinical Trial Update: Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine [Phase 2]
Summary
Phase 2 trial evaluating a low-dose naltrexone and acetaminophen combination for acute treatment of migraine has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allodynic Therapeutics, Inc | Conditions: Migraine With or Without Aura | Phase 2 | Status: COMPLETED